Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
778274-97-8	N-(2-Hydroxyethyl)-4-(6-((4-(trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide C1=CC(=CC=C1C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F)C(=O)NCCO	C₂₀H₁₇F₃N₄O₃	418.4	98%	Click to inquire
1327167-19-0	N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)C4=CC(=CC=C4)NS(=O)(=O)C5=CC=CC=C5	C₂₇H₂₈N₆O₃S	516.6	98%	Click to inquire
318290-98-1	Fluensulfone C1=C(SC(=N1)S(=O)(=O)CCC(=C(F)F)F)Cl	C₇H₅ClF₃NO₂S₂	291.7	98%	Click to inquire
1016535-83-3	2-(4-((4-Fluorobenzyl)oxy)phenyl)acetonitrile C1=CC(=CC=C1CC#N)OCC2=CC=C(C=C2)F	C₁₅H₁₂FNO	241.26	98%	Click to inquire
635324-72-0	CTLA-4 inhibitor CN1C2=NC(=C3C(=C2C=N1)NN(C3=O)C4=CC=C(C=C4)F)C5=CC(=CC=C5)C(F)(F)F	C₂₁H₁₃F₄N₅O	427.4	98%	Click to inquire
671225-39-1	Cardiogenol C COC1=CC=C(C=C1)NC2=NC=CC(=N2)NCCO	C₁₃H₁₆N₄O₂	260.29	98%	Click to inquire
5452-87-9	N-Methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethanamine CN(CCC1=CC=CC=N1)CCC2=CC=CC=N2	C₁₅H₁₉N₃	241.33	98%	Click to inquire
1346528-06-0	2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine C1CCC2=C(C1)C(=NC(=N2)N3CCOC4=CC=CC=C43)NCC5=CC=CC=C5	C₂₃H₂₄N₄O	372.5	98%	Click to inquire
82351-05-1	Lvguidingan CCC(C)NC(=O)C=CC1=CC(=C(C=C1)Cl)Cl	C₁₃H₁₅Cl₂NO	272.17	98%	Click to inquire
1093757-42-6	(1S,2R)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid C1CCC(C(C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)C(=O)O	C₁₄H₁₅Cl₂NO₃	316.2	98%	Click to inquire

N-(2-Hydroxyethyl)-4-(6-((4-(trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide

Multi-kinase inhibitor 1

C₂₀H₁₇F₃N₄O₃ 418.4

N-[5-[3-(benzenesulfonamido)phenyl]-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide

C₂₇H₂₈N₆O₃S 516.6

C₇H₅ClF₃NO₂S₂ 291.7

2-(4-((4-Fluorobenzyl)oxy)phenyl)acetonitrile

C₁₅H₁₂FNO 241.26

CTLA-4 inhibitor

C₂₁H₁₃F₄N₅O 427.4

CARDIOGENOL C HCL

C₁₃H₁₆N₄O₂ 260.29

N-Methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethanamine

N-Methyl-N,N-bis(2-pyridylethyl)amine

C₁₅H₁₉N₃ 241.33

2-(2H-benzo[b][1,4]oxazin-4(3H)-yl)-N-benzyl-5,6,7,8-tetrahydroquinazolin-4-amine

C₂₃H₂₄N₄O 372.5

C₁₃H₁₅Cl₂NO 272.17

(1S,2R)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid

C₁₄H₁₅Cl₂NO₃ 316.2

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15561) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号